Teva Scores FCA Trial Delay, Kickback Law Appeal At 1st Circ.
Teva Pharmaceuticals won a major reprieve Monday when a Massachusetts federal judge delayed an impending False Claims Act trial threatening $10 billion in liability and permitted the drugmaker to pursue First...To view the full article, register now.
Already a subscriber? Click here to view full article